European Archives - Page 15 of 1530 - European Medical Journal

ERA 2026 Interview: Serhan Tuğlular

I completed my fellowship in Nephrology at Marmara University School of Medicine, Istanbul, Türkiye, in 1999. My primary clinical and…

The AI Revolution: London Tech Week 2026

The UK government has launched major investments in AI and plans for workforce transformation at London Tech Week 2026.

The Next Frontier in Healthcare: Interview with Lord David Gifford Leathes Prior

In terms of both diagnostics and therapeutics, the UK is extremely well positioned in science…

Endometriosis

ESHRE 2026: Mood Changes Drive Low Satisfaction with Hormonal Therapy

Women with endometriosis and adenomyosis report low satisfaction with hormonal therapy, with mood changes emerging as the strongest predictor of dissatisfaction.

NHS App to Launch New AI Triage Tool

The NHS App is set to launch a new AI triage tool, designed to cut waiting times and improve patient care.

IVF add-ons

Evidence Behind IVF Add-Ons Deemed Insubstantial and Poor

New research has found that evidence behind the effectiveness of IVF treatment add-ons is poor.

EHA Lifetime Achievement 2026 Awardee: Claire Harrison

Before the advent of JAK inhibitors, we did not have any effective therapy for patients with myelofibrosis. We could offer them a…

Haleon enters five-year AI pact with Microsoft

Haleon has partnered with Microsoft in a new five-year collaboration to scale AI capabilities across the business.

systemic lupus erythematosus

Anifrolumab Shows Real-World Promise in Systemic Lupus Erythematosus

New real-world data show anifrolumab reduces disease activity and calms interferon-driven immune signals in active systemic lupus erythematosus.

rosacea

Ivermectin, E-BPO Outperform Metronidazole in Rosacea

A network meta-analysis found topical ivermectin and encapsulated benzoyl peroxide were more effective than metronidazole for moderate-to-severe rosacea.